Target intelligence / Profile preview

AT-rich interaction domain-containing protein 3C (ARID3C)

Target
ARID3C
Molecular classification
Transcription factor, Chromatin-binding protein, Member of the ARID (AT-rich interaction domain) family
01

Overview

ARID3C, or AT-rich interaction domain-containing protein 3C, is a member of the ARID family of transcription factors that contains a helix-turn-helix motif-based DNA-binding ARID domain[2]. It is expressed at low levels in various tissues and functions in the nucleus, where it acts as a transcription factor that regulates the expression of genes involved in monocyte-to-macrophage differentiation, specifically STAT3, STAT1, and JUNB[1][2]. ARID3C forms a complex with NPM1 to translocate to the nucleus, and its loss of nuclear localization disrupts its transcriptional activity and cellular differentiation role[1]. Unlike related ARID3 family members (such as ARID3A and ARID3B), ARID3C has not been directly implicated in common diseases or cancers and is not currently known as a drug target[1][2].

Other names
AT-rich interaction domain 3CAT-rich interactive domain-containing protein 3CARID3CBrightlikeARID domain-containing protein 3CAT-rich interactive domain 3C (BRIGHT-like)
02

Biological functions

Transcriptional regulation (acts as a transcription factor for genes such as STAT3, STAT1, and JUNB)Regulation of monocyte-to-macrophage differentiationCell lineage gene regulationChromatin bindingPossibly involved in chromatin structure modification
03

Disease associations

Other (No direct disease role reported for ARID3C as distinct from its paralogs such as ARID3A, which have established roles in cancer)

Beyond the preview

Go deeper on AT-rich interaction domain-containing protein 3C (ARID3C).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on AT-rich interaction domain-containing protein 3C (ARID3C).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call